Alginate / Antacid Combination
Pregnancy: Compatible — commonly used first-line for heartburn in pregnancy; sodium content noted but systemic absorption negligible.
Gaviscon Advance (Alginate Preparation)
Brand names: Gaviscon Advance
Adult dose
Dose: 10mL (or 2 chewable tablets) after meals and at bedtime — maximum 4 doses per day.
Route: Oral
Frequency: After meals and at bedtime (maximum QDS)
Max: 40mL liquid or 8 tablets per day
Sodium alginate 500mg + potassium bicarbonate 267mg per 5mL. Forms a viscous raft on gastric contents, reducing acid reflux into oesophagus. Not a systemic drug — acts locally. Contains sodium (400mg/10mL) — caution in heart failure, hypertension, renal impairment.
Paediatric dose
Route: Oral
Frequency: After feeds
Max: 10mL per dose (children ≥2 years)
Infants: Infant Gaviscon sachets (different formulation — sodium alginate only) — 1 sachet per feed (breast or bottle). Children ≥2 years: 5–10mL after meals under medical supervision. Source: BNF for Children 2024.
Dose adjustments
Renal
Use with caution — contains potassium (risk of hyperkalaemia in renal failure).
Hepatic
No dose adjustment required.
Clinical pearls
- Raft mechanism: alginate reacts with gastric acid to form a gel raft that floats on gastric contents — physically prevents acid reflux, not acid suppression.
- Sodium content: Gaviscon Advance liquid 10mL contains 141mg sodium. Relevant in heart failure, hypertension, sodium-restricted diets.
- Better than liquid antacids for post-prandial reflux — alginate raft persists longer than antacid effect.
- Gaviscon Advance (adult) and Infant Gaviscon are DIFFERENT formulations — do not substitute one for the other.
Contraindications
- Severe renal failure (potassium and sodium content)
- Hypercalcaemia (calcium-containing antacid components in some formulations)
Side effects
- Flatulence (common — CO₂ from reaction with stomach acid)
- Constipation (mild)
- Hyperkalaemia (rare — with high doses in renal failure)
Interactions
- May impair absorption of other oral drugs if taken simultaneously — separate by 2 hours
- Digoxin, tetracyclines, fluoroquinolones: reduced absorption (timing important)
Monitoring
- Symptom response
- Potassium (if renal impairment and regular use)
Reference: BNFc; BNF 90; NICE CG62 Dyspepsia and GORD; SPC Gaviscon Advance. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021